IPO values iconic bootmaker at £3.7bn

Dr Martens, the Northampton-based footwear manufacturer, has confirmed its flotation price.

The firm says the IPO will be run at 370p per share, valuing it at £3.7bn when it is admitted to the Main Market today (January 29).

Kenny Wilson, CEO of Dr Martens, said: “We have been delighted by the strong levels of interest, engagement and support from such a high quality selection of institutional investors.

“The successful transformation of Dr Martens is a great story, and what is even more exciting is the huge potential ahead. We are proud to take our place as a London listed company, both delivering as a successful plc and more importantly continuing to grow our brand around the world.”